Topical dosage form comprising plant butter extracted from diploknema butyracea

IN605599BActive Publication Date: 2026-10-12QUANTUM UNIV +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
IN202311085994
Authority / Receiving Office
IN · IN
Patent Type
Patents
Current Assignee / Owner
Filing Date
2023-12-16
Publication Date
2026-10-12
Estimated Expiration
2043-12-16

AI Technical Summary

Technical Problem

Current topical formulations face challenges in achieving effective and localized delivery of pharmaceutical agents, absorption through the skin barrier, patient comfort, and environmental sustainability, with a need for a plant-based base that minimizes skin irritation and provides a non-greasy texture.

Method used

A topical dosage form utilizing plant butter extracted from Diploknema Butyracea as the base, combined with Diclofenac sodium and a penetration enhancer like menthol, to enhance skin penetration and stability, while using Tween 80 as an emulsifier for improved texture and spreadability.

Benefits of technology

The formulation achieves effective and targeted drug delivery, improved skin penetration, and a comfortable, non-greasy application experience, while being eco-friendly and cost-effective, with enhanced stability and skin compatibility.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

ABSTRACT TOPICAL DOSAGE FORM COMPRISING PLANT BUTTER EXTRACTED FROM DIPLOKNEMA BUTYRACEA The present invention relates to topical preparations and formulation useful for the delivery of medicaments. It comprises of Diclofenac sodium as an active ingredient, penetration enhancer, tween 80 and a base comprising plant butter extracted from Diploknema butyracea in a range between 60 – 90 % w / v of total composition. Topical formulation of the present invention comprising the base of plant butter extracted from Diploknema butyracea have good base property as it ensures that the drug can release to the skin, It also ensures the effective and localized application of pharmaceutical agent to specific areas of the skin.
Need to check novelty before this filing date? Find Prior Art

Description

FIELD OF INVENTIONThe present invention relates to topical preparations and formulations useful for the delivery of medicaments.BACKGROUND OF THE INVENTIONTopical formulations are intended for the application on the skin to produce and local and systemic effect at the site of application. These include creams, ointments, pastes, emulsion gel and rigid form, wherein one or more therapeutic agent is uniformly dissolved in an appropriate base and some suitable excipients such as preservatives, antimicrobial agent emulsifier, antioxidant etcThe choice of base in topical preparations holds immense significance in pharmaceutical formulations, as it serves as the fundamental vehicle for delivering active pharmaceutical ingredients (APIs) to target tissues. The base plays a pivotal role in determining the efficacy, stability, and overall performance of the topical medication. Its impact on the delivery and absorption of APIs into the skin or mucous membranes is crucial, influencing factors such as solubility, dispersion, and release kinetics.Moreover, the base's influence on the penetration of medication through the skin barrier is a critical consideration, with different bases exhibiting varying degrees of occlusivity. This property directly affects the rate at which active ingredients are absorbed, making it a key factor in achieving therapeutic outcomes. Additionally, the stability of the formulation, including the chemical stability of APIs, is influenced by the choice of base, which may either enhance or inhibit degradation over time.Patient comfort and compliance are also heavily dependent on the characteristics of the base. Factors such as texture, consistency, greasiness, and potential irritation contribute to the overall user experience, impacting adherence to the prescribed regimen. Furthermore, the compatibility of the base with different skin types is crucial to minimize adverse reactions, ensuring broad patient applicability.Formulation flexibility is another notable aspect, with the base serving as a platform for customization based on the desired product characteristics, such as cream, gel, ointment, or lotion. The hydration and moisturizing properties of certain bases contribute to their therapeutic potential, especially in conditions requiring additional skin hydration. Topical compositions containing a variety of base are disclosed in a number of prior art publications. U.S. Patent publication US5512278A discloses ointment base useful for preparing topically applied medicament formulations, comprising a stable emulsion of at least about 10% by weight of each of water, one or more paraffins, and a liquid polyol; and less than about 10% by weight of each of beeswax, cetostearyl alcohol, a 4-hydroxy benzoic acid lower alkyl ester, a surface active agent, and a dispersing agent. US5914334A shows gel formulation comprising water, edetate disodium, ascorbic acid, Carbomer 934P, Poloxamer 407, polyethylene glycol, Polysorbate 40, hexylene glycol, butylated hydroxytoluene, butylated hydroxyanisole, benzyl alcohol, and tromethamine as pharmaceutical carrier. EP0763362B1 relates to pharmaceutical base containing 5 % to 25 % by weight of beeswax and 95 % to 75 % by weight of a hydrophobic solvent selected from vegetable oil and animal oil, and having a netted framework structure constituted by beeswax, in which said hydrophobic solvent is included, said netted framework structure resulting from spontaneously cooling beeswax, in mixture with the preheated hydrophobic solvent.Despite all these approaches and attempts, plant-based base is favored in topical formulations for their natural and sustainable attributes, offering reduced skin sensitivity and irritation. Therefore, there is a need in the art to develop plant-based base having natural ingredients for delivery of topical composition. OBJECTIVE OF THE INVENTIONThe objective of the present invention is to provide a topical dosage form that facilitates targeted drug delivery, ensuring the effective and localized application of pharmaceutical agents to specific areas of the skin. It is another objective of the present invention to enhance the absorption and penetration of active pharmaceutical ingredients through the skin barrier, optimizing the therapeutic efficacy of the topical composition. It is another objective of the present invention to provide lightweight and non-greasy texture, providing a pleasant application experience that feels comfortable on the skin without leaving a heavy residue.It is another objective of the present invention to provide for an efficacious and cost-effective solution for topical compositions. It is yet another objective of the present invention to provide a composition that is free of harmful chemical base. SUMMARY OF THE INVENTIONThis summary is provided to disclose the concepts related to a topical dosage form comprising base of plant butter extracted from Diploknema Butyracea, wherein using a plant-based base in topical pharmaceutical compositions aims to leverage the inherent therapeutic properties of plants while prioritizing skin compatibility, targeted drug delivery, and environmental sustainability. These objectives contribute to the development of effective, well-tolerated, and eco-friendly topical pharmaceutical solutions. This summary is not intended to identify essential features of the claimed subject matter nor is it intended for use in determining or limiting the scope of the claimed subject matter.An aspect of the invention relates to an oral care composition, comprising: - Diclofenac sodium as an active ingredient in an amount in a range between 1 - 20 % w / v of total composition; - penetration enhancer in an amount in a range between 0.1 - 5 % w / v in the topical formulation; - tween 80 in a range between 10 - 20 % w / v of total composition; - base comprising plant butter extracted from Diploknema butyracea in a range between 60 - 90 % w / v of total composition.Another aspect of the invention relates to a method of preparation of this composition and its evaluation. Still other embodiments of the present invention will become readily apparent to those skilled in the art from the following detailed description, wherein are described embodiments by way of illustrating the best mode contemplated for carrying out the invention. As will be realized, the invention is capable of other and different embodiments and its several details are capable of modifications in various obvious respects, all without departing from the spirit and the scope of the present invention. Accordingly, the detailed description is to be regarded as illustrative in nature and not as restrictive.DETAILED DESCRIPTION OF THE INVENTION Some embodiments of this disclosure, illustrating all its features, will now be discussed in detail. The words "comprising," "having," "containing," and "including," and other forms thereof, are intended to be equivalent in meaning and be open ended in that an item or items following any one of these words is not meant to be an exhaustive listing of such item or items, or meant to be limited to only the listed item or items.Although any methods similar or equivalent to those described herein can be used in the practice or testing of embodiments of the present disclosure, the exemplary methods are now described. The described embodiments are merely exemplary of the disclosure, which may be embodied in various forms.Various modifications to the embodiment will be readily apparent to those skilled in the art and the generic principles herein may be applied to other embodiments. However, one of ordinary skill in the art will readily recognize that the present disclosure is not intended to be limited to the embodiments illustrated, but is to be accorded the widest scope consistent with the principles and features described herein. An embodiment of the invention relates to a topical composition comprising a Diclofenac sodium in a base comprising plant butter extracted from Diploknema butyracea.Diclofenac sodium is a non-steroidal anti-inflammatory drug and shows both analgesic and antipyretic activity. It can be used topically for the various treatment such as post operative ocular inflammation in cataract extraction.The composition comprises base made of plant butter extracted from Diploknema butyracea, also known as by Bassia Butyracea (Roxb. Madhuca Butyracea (Roxb.), and commonly known as Chyuri or Indian Butter Tree. The main constituents of butter are Triglycerides and Fatty acids. It is frequently cultivated, mainly for the Ghee obtained from the seed. The butter extracted from the seed is known as "Chyuri Ghee" or "Phulwara Butter" is the most used product from the tree. The chyuri ghee is used for many purposes such as for making soap and candles.The extraction process is essential for obtaining a natural and valuable ingredient from the Diploknema butyracea seeds. The extraction process of Diploknema butyracea plant butter involves a series of carefully orchestrated steps to derive the valuable butter from the seeds of the Diploknema butyracea tree. a) Selection And Collection Of Plant Material:It is an important to select and the collect the effective plant material for the isolation of active phyto-constituent. For the plant extraction only healthy and diseases free plant is selected and comprises the following steps:b) Drying Of Plant Material:The active constituent of plant material is produced by active enzymes which is present in fresh plant material. Therefore, the drying process has an importance in extraction process.c) Size Reduction:The reduction of size of the plant material is very important in extraction process. Small size particles have high efficiency towards extraction process. Size of plant material is reduced by the hammer mill, grind machine etc.d) Selection Of Suitable Solvent:The solvent is selected on the bases of pyto-constituent extraction process and petroleum ether is most commonly used solvent in many extraction process.e) Extraction Process:The extraction process is done by soxhlet extractor.The base of the present invention is particularly useful for preparing formulations containing a plurality of different medicaments. Such formulations can be prepared, for instance, by preparing individual formulations of the medicaments, and then combining the resultant single-medicament formulations with each other in a desired manner and concentration.In a preferred embodiment, Diclofenac sodium used as an active ingredient in the topical formulation. It is present in an amount in a range between 1 - 20 % w / v in the topical formulation, preferably in a range of 1 -10 % w / v by weight of the composition, preferably in an amount of 1.5 gm.In another embodiment of the invention, menthol is used as penetration enhancer. It increases the penetration of drug into the skin and enhances the diffusion rate into the skin and allow the drug particles to enters the skin. Menthol is highly lipid soluble and therefore crosses the skin barrier. It is present in an amount in a range between 0.1 - 5 % w / v in the topical formulation, preferably in a range of 0.2 -2.5 % w / v by weight of the composition, preferably in an amount of 0.5 ml. In yet other embodiment, Tween 80 is present in an amount in a range between 10 - 20 % w / v in the topical formulation, preferably in an amount of 2.5 ml in the topical formulation. It is used as an emulsifier and wetting agent and is used to stabilize emulsions and improve their texture and spreadability. It is derived from polyethoxylated sorbitan and oleic acid.In a further embodiment, the base comprising plant butter extracted from Diploknema butyracea of the present invention is present in an amount in a range between 60 - 90 % w / v in the topical formulation. Since the base serves as the vehicle for delivering the active components of the topical formulation, its quantity is determined by the desired consistency, texture, and efficacy of the product. In a preferred embodiment, it is present in an amount of 15 ml in the topical formulation.EXAMPLESThe invention is illustrated by the following examples which are only meant to illustrate the invention and not to act as limitations. All embodiments apparent to a process there in the art are deemed to fall within the scope of the present invention. Example 1: Preparation of topical cream formulation:For the formulation of 1.5 grams of diclofenac sodium were accurately weighed and dissolved in a minimum amount of ethanol in a beaker. Subsequently, 2.5 milliliters of tween 80 were dissolved in a sufficient amount of distilled water, and the entire content was poured into the drug solution with constant stirring, constituting the aqueous phase or dispersion medium. In another beaker, 15 milliliters of plant butter were taken, and 0.5 milliliters of menthol (a penetrating enhancer) were added, forming the oily phase or dispersed phase. The aqueous and oily phases were then heated at 50°C for a few minutes. The oily phase was slowly added to the aqueous phase with constant stirring using a magnetic stirrer (see Fig. 2), and the emulsion was made up to 50 milliliters using distilled water.Table 1: Example 2: Evaluation of topical cream composition The prepared formulation was stable, containing butter as oily phase and menthol as penetrating enhancer showed best result. The evaluation test result showed that the plant butter can be used as base in topical formulation and menthol showed good result as penetrating enhancer. The plant butter extracted from Diploknema butyraceahave can provide body to any topical formulation.Various test for the evaluation of formulation were conducted.Colour: The colour of the formulation was creamy white.pH: pH is a major determinant of the stability, solubility and other pharmaceutical qualification of drug. The pH was determined by the digital pH meter. The pH of the formulation was found to be 6.86 i.e., the formulation was slightly acidic in nature.Spreadability: Spreadability is define as the ability of formulation to evenly spread on the skin.value. The spreadability value shows the extent at which the formulation is spreaded on the site of application. Thespreadability was measured by the glass slide apparatus. The spreadability of formulation was found to be 3.04 gcm / sec. Homogenity: By visual inspection homogeneity was tested. The formulation was set in the container and there were no aggregates formed i.e., homogeneity of formulation was good.Density: The density of formulation was found to be 1.108 g / ml.Drug release: Drug release test is important to know the efficacy and quality of the formulation. It was done by Franz diffusion cell apparatus. The maximum percentage drug release was found to be 0.86%.The prepared formulation of the present invention showed that the plant butter extracted from Diploknema butyracea does not binds drug, it can release drug to the skin, having good base property.

Claims

1. A topical dosage composition comprising: - Diclofenac sodium as an active ingredient in an amount in a range between 1 - 20 % w / v of total composition; - penetration enhancer in an amount in a range between 0.1 - 5 % w / v in the topical formulation; - Tween 80 in a range between 10 - 20 % w / v of total composition; - base comprising plant butter extracted from Diploknema butyracea in a range between 60 - 90 % w / v of total composition.

2. The topical dosage composition as claimed in claim 1, wherein menthol is used as a penetration enhancer.

3. The topical dosage composition as claimed in claim 1, wherein petroleum ether is used as a solvent for extraction of plant butter from Diploknema butyracea.

4. The topical dosage composition as claimed in claim 1, wherein base comprising plant butter is present in a range between 60 - 90 % w / v of total composition.

5. The process for the preparation of topical dosage composition of claim 1 comprising a. dissolving diclofenac sodium in a minimum amount of ethanol in a beaker; b. dissolving tween 80 in a sufficient amount of distilled water, and pouring the entire content into the drug solution with constant stirring, constituting the aqueous phase or dispersion medium; c. adding plant butter and menthol, forming the oily phase or dispersed phase; d. heating the aqueous and oily phases at 50°C for a few minutes; e. adding oily phase to the aqueous phase with constant stirring using a magnetic stirrer and making up the emulsion using distilled water.